Biotech & Pharma H-1B Sponsors for Non-Scientist Roles (Tech, PM, Data) 2026

Biotech and pharma companies sponsor H-1B for tech, PM, and data roles too — here is how to find them and win those petitions in 2026.

When you picture a biotech or pharma company sponsoring H-1B visas, you probably imagine a bench scientist or a clinical researcher. That picture is incomplete. Behind every drug candidate moving through IND filing, behind every CTMS platform handling trial data, and behind every commercial launch analytics stack is a team of software engineers, data engineers, product managers, and technical program managers — many of them on H-1B. These companies need that talent, and they sponsor it.

The challenge is that job boards rarely surface these roles as "visa-sponsored" even when the employer has a consistent sponsorship track record. You need to know which companies to target, how to verify their H-1B history before you invest time in an application cycle, and how the 2026 rule changes affect your odds in ways that are actually favorable for senior technical hires. This guide covers all of that.

Why life sciences companies hire non-scientist tech talent

Biotech and pharma companies have become technology-intensive operations. Clinical trial data management requires engineers who can build pipelines that comply with 21 CFR Part 11 and FDA data integrity rules. Drug discovery platforms use machine learning infrastructure comparable to what you would find at any AI lab. Commercial operations teams run analytics stacks to track prescriptions, market share, and formulary access. Digital health subsidiaries need mobile and web engineers. Regulatory affairs teams use software engineers to build submission management tools.

This means a software engineer with domain awareness, a data engineer who understands GxP validation, or a product manager with experience in regulated industries is genuinely differentiated — and worth the cost and administrative overhead of H-1B sponsorship. For more on the general biotech H-1B landscape, see our overview of biotech and life sciences H-1B sponsorship.

Which types of employers sponsor in this space

Large pharma and established biotechs

Companies like Johnson & Johnson, Pfizer, Merck, AstraZeneca, Roche/Genentech, Amgen, Gilead, AbbVie, Bristol-Myers Squibb, Eli Lilly, and Novartis have large tech and data organizations and documented H-1B sponsorship histories. Their internal platforms teams, commercial analytics groups, and clinical data engineering functions all hire non-scientist technical staff. USCIS H-1B disclosure data — published annually and searchable on the DOL disclosure database — shows these employers filing hundreds of H-1B petitions per year across job titles that go well beyond scientists.

For a deeper look at the broader pharmaceutical industry visa landscape, read our piece on pharmaceutical industry visa sponsorship.

CROs and CDMOs

Contract research organizations (CROs) like IQVIA, Covance (part of Labcorp), Parexel, and PPD (now Thermo Fisher Scientific) and contract development and manufacturing organizations (CDMOs) are active H-1B sponsors. Their data science, bioinformatics, and clinical trial technology teams hire engineers and analysts directly. CROs in particular operate large technology platforms for electronic data capture and real-world evidence analysis.

Well-funded biotechs (Series B and beyond)

Well-funded biotechs have both the cash to cover filing fees and the infrastructure to handle the H-1B process. Series B and later-stage companies with at least one internal platform or commercial product are realistic targets. Series A companies can sponsor, but verify that they have committed immigration counsel and financial stability before banking on them.

Healthtech and digital health companies

Companies at the intersection of software and life sciences — electronic health records companies, clinical decision support platforms, pharma CRM vendors, and genomic testing platforms — sponsor aggressively. These companies are essentially software companies with healthcare clients and often have more fluid hiring processes for tech roles than traditional pharma.

Roles that qualify under H-1B specialty occupation

H-1B requires the position to qualify as a "specialty occupation" under 8 CFR § 214.2(h)(4)(ii) — generally meaning the role requires a bachelor's degree or higher in a directly related specific field. The following roles routinely qualify in the biotech/pharma context:

The H-1B Modernization Rule, which took effect January 17, 2025, revised the specialty-occupation standard to require the position to "normally" require a specific bachelor's degree — removing the prior language that allowed multiple degrees to qualify a single role. For product manager and technical program manager roles, work with your employer's counsel to ensure the job description is written to document specific technical degree requirements clearly.

The 2026 lottery and fee rules — what actually affects you

Wage-weighted lottery

The wage-weighted H-1B lottery, effective February 27, 2026, changed how registration entries are assigned. Workers registered at DOL prevailing wage Level III or Level IV receive additional entries, resulting in projected selection odds of approximately 45–61% for that cohort. Entry-level registrations at Level I or II have lower odds.

For you as a senior software engineer, data engineer, or data scientist targeting biotech employers in high-cost metros like Boston, San Francisco Bay Area, San Diego, or the Research Triangle, this is relevant: these metros have high prevailing wages, and senior-level roles frequently map to Level III or IV. If your employer registers you at the correct wage level, your lottery odds improve materially compared to prior years.

Discuss with your employer's immigration counsel what wage level your petition will be registered at before the FY2028 registration window opens. A Level II registration that should be Level III both underrepresents your compensation and sacrifices lottery entries.

The $100,000 supplemental fee

A $100,000 supplemental fee now applies to certain new cap-subject H-1B petitions. This fee does not apply to F-1 students changing status from within the United States — a significant carve-out for OPT and STEM OPT candidates filing cap-subject H-1B petitions while already in the US. Confirm the exact applicability with your employer's counsel, as the fee rules have specific conditions and the USCIS FAQ should be treated as the authoritative reference.

For more on the fee and who is exempt, see our detailed analysis of whether the $100K fee applies to OPT students.

How to verify H-1B sponsorship before applying

Don't rely on a job posting's absence of "visa sponsorship available" language as a negative signal. Many biotech and pharma employers sponsor routinely but don't flag it in postings.

Step-by-step verification process

1. Search DOL H-1B disclosure data. The Department of Labor publishes quarterly H-1B disclosure reports. Search by employer name and filter for non-research job titles (Software Engineer, Data Engineer, etc.). Any employer who has filed LCAs for these roles recently is an active sponsor.

2. Use USCIS employer data tool. USCIS publishes annual employer H-1B petition data. Search by company name and look at approval/denial rates. High approval rates on prior petitions for similar roles are a positive signal.

3. Search LinkedIn for H-1B holders at the company. Filter for employees with "H-1B" mentioned in their public profiles or look for people who graduated from US universities with F-1 visas and are now at the company in technical roles. If a pattern exists, the company sponsors.

4. Ask during the recruiter screen. A professional, direct ask — "Does your company sponsor H-1B for this role?" — is expected from international candidates. A recruiter who is evasive or unclear is itself a data point.

5. Check our resource on how to verify sponsorship. Our detailed guide on how to check if a company sponsors H-1B covers additional methods including FOIA requests and H-1B job board databases.

Boston, San Diego, and the Research Triangle as target metros

Geography matters in life sciences. These three clusters have high concentrations of biotech employers with active tech hiring.

Boston/Cambridge: Dense concentration of biotech companies along the Kendall Square / Seaport / Waltham corridor. Academic medical centers like Mass General Brigham and Beth Israel Deaconess are cap-exempt H-1B employers with large IT and clinical informatics teams. For general metro strategy, see Boston H-1B biotech and university jobs guide.

San Diego: Major biotech hub anchored by companies like Illumina, Dexcom, Qualcomm Life (digital health), and numerous clinical-stage biotechs. Software and data engineering roles are active. See San Diego H-1B jobs: biotech and defense.

Research Triangle (NC): Pharmaceutical manufacturing and CRO presence (GSK, Bayer, IQVIA) with growing digital health hiring. Lower cost of living than Boston or SF means prevailing wages can still map to Level III at a more affordable overall compensation. See Research Triangle NC H-1B jobs in pharma and tech.

Data roles in life sciences specifically

Data engineering and data science roles in pharma have a specific flavor worth understanding. Clinical data engineers work with CDISC standards (SDTM, ADaM) used in regulatory submissions. Real-world evidence analysts work with claims data and EHR data under strict data governance. Pharmacovigilance analytics teams monitor safety signals using structured statistical pipelines.

If you have standard data engineering skills plus domain familiarity with any of these areas — even from coursework, a thesis, or an adjacent healthcare internship — you are genuinely differentiated. Employers are not expecting pure bench scientists; they are looking for engineers who can navigate a regulated environment.

For more on H-1B targeting strategies for data roles specifically, see our guide to data engineer H-1B sponsorship.

Cap-exempt strategy for biotech tech roles

If you are coming off STEM OPT and want to reduce your dependence on the lottery, the cap-exempt path is worth understanding seriously.

Cap-exempt H-1B employers include nonprofit research institutions, universities, and government research organizations. In the life sciences context, this means university-affiliated research hospitals, academic medical centers, NIH-funded research institutes, and nonprofit genomics organizations. They can file H-1B petitions year-round without entering the lottery.

The strategy: get your first H-1B through a cap-exempt employer, then transfer to a cap-subject biotech or pharma company using AC21 portability after the petition is approved. Once you have been counted against the cap (even through a cap-exempt employer's filing), you are cap-exempt for all future transfers — meaning you can move to a fully commercial biotech without re-entering the lottery. See our detailed breakdown of cap-exempt H-1B employers and the cap-subject versus cap-exempt career tradeoffs.

Product manager roles and what makes them work

Product manager H-1B petitions in biotech require more upfront documentation than engineering roles because the specialty-occupation argument is less self-evident to USCIS adjudicators. The job description needs to articulate clearly that:

• The role requires a specific bachelor's degree (not "a degree in any field")
• The duties are technical and domain-specific (not general business management)
• Industry practice for this type of PM role requires a technical or scientific degree

Strong PM H-1B cases in biotech typically involve roles like clinical data platform PM, regulatory technology PM, digital health product manager, or commercial analytics product manager — all of which can be grounded in specific technical degree requirements. Entry-level "associate PM" roles with vague responsibilities are the ones that generate RFEs.

If you are targeting PM roles, our guide on product manager H-1B sponsorship for international candidates covers the specialty-occupation documentation strategy in full.

Common mistakes

Assuming large pharma companies don't sponsor for tech roles. They do. The same Pfizer that employs thousands of scientists employs hundreds of engineers. Their internal portals and external job boards are worth checking directly.

Targeting only the job posting title, not the team. A "data analyst" at a pharma company might be doing complex pharmacovigilance signal detection that maps to a much stronger H-1B case than the title suggests. Look at the actual duties.

Accepting a Level I wage registration when your experience warrants Level III. Employers sometimes propose lower wage levels to reduce their LCA cost. Level I and Level II registrations have lower lottery odds under the wage-weighted system. Know what level your offer maps to and advocate for the correct placement.

Ignoring CROs and CDMOs. These organizations are active sponsors with less competitive hiring processes than large pharma for tech roles. IQVIA and Labcorp file large numbers of H-1B petitions annually.

Underestimating the startup risk without doing diligence. Biotech startups often have less institutional knowledge about H-1B than large employers. Ask explicitly whether they have engaged outside immigration counsel and whether they have sponsored H-1B before. A startup that has never done it and doesn't have legal support introduces meaningful risk.

Skipping premium processing when timing matters. USCIS offers H-1B premium processing for $2,965 (as of 2026) guaranteeing adjudicative action within 15 business days. For cap-year petitions where your OPT end date is tight, premium processing is almost always worth it.

Frequently asked questions

Do biotech and pharma companies sponsor H-1B for software engineers and data roles?

Yes. Large pharma companies and well-funded biotechs regularly sponsor H-1B for software engineers, data engineers, data scientists, and platform engineers. These roles qualify under the H-1B specialty-occupation standard because they require a bachelor's degree or higher in a directly related technical field. The sponsorship process is identical to a tech-company H-1B petition.

Does the $100,000 supplemental H-1B fee apply to F-1 students changing status inside the US?

No. The $100,000 supplemental fee applies to certain new cap-subject H-1B petitions for workers outside the United States. F-1 students filing a change of status from within the US are generally exempt from this fee. Confirm the exact applicability with your employer's immigration counsel before the petition is filed.

How does the wage-weighted lottery affect non-scientist tech roles in biotech?

Under the wage-weighted lottery rule effective February 27, 2026, workers registered at DOL wage Level III or Level IV receive more entries and higher projected selection odds of roughly 45–61%. Senior software engineers and data engineers in biotech metro areas often reach Level III or IV thresholds, which improves lottery odds compared to entry-level registrations.

Are biotech startups able to sponsor H-1B or only large pharma companies?

Many biotech startups do sponsor H-1B, but you need to verify their capacity before accepting an offer. Key checks are USCIS H-1B disclosure data showing prior approvals, clear evidence of ongoing funding (Series B or later is a good signal), and a stated willingness to engage outside immigration counsel. Series A startups can sponsor but introduce more risk if their financials are thin.

What is the cap-exempt strategy for biotech tech roles and how does it work?

Cap-exempt employers include nonprofit research institutions, universities, and government research organizations. Some academic medical centers and university-affiliated research institutes fall into this category. If you join such an employer first, you can secure H-1B status outside the lottery entirely, then transfer to a cap-subject biotech or pharma company later using AC21 portability without re-entering the lottery.

If you are weighing which employers to target, how to present your visa situation in interviews, or how to sequence your OPT and STEM OPT optimally before the FY2028 registration window, F1Jobs works with candidates in exactly this situation every month. The path into biotech and pharma tech is real — you just need to approach the right companies with the right documentation.